№172|11:56 PM ET
Independent reporting on technology, markets & policy
TechEchelon
№01 / Anchor·POLITICS

Biden Administration Invests $24 Million in mRNA Research to Revolutionize Cancer Treatment

Leading the research will be a team from Emory University, based in Atlanta. The funds for this project will come from the Advanced Research Projects Agency for Health (ARPA-H), an initiative created to support groundbreaking and high-potential research.

TE
TechEchelon Staff
AUG 24, 2023 · 04:29 PM ET · 1 MIN READ
Editorial

Leading the research will be a team from Emory University, based in Atlanta. The funds for this project will come from the Advanced Research Projects Agency for Health (ARPA-H), an initiative created to support groundbreaking and high-potential research.

This initiative aligns with President Biden's "cancer moonshot" ambition, which targets a 50% reduction in cancer mortality by 2047.

Both the moonshot and ARPA-H initiatives fall under Biden's "unity agenda," which he unveiled during his 2022 State of the Union speech. This agenda promotes bipartisan unity on vital issues, such as the fight against cancer.

This is the inaugural award from ARPA-H since it began accepting proposals last year.

The overarching aim of this project is to establish a comprehensive suite of mRNA and associated technologies. Such tools can potentially "activate" beneficial immune reactions, like urging immune cells to zero in on and combat tumors, as per the statement from the White House. The potential of this technology isn't limited to cancer; it could also be valuable in managing autoimmune diseases, transplants, and infectious conditions.

Biden emphasized the significance of mRNA technology by highlighting its role in the development of COVID-19 vaccines, which have been crucial in saving countless lives globally. He mentioned, "These therapies ... underscore the essence of American creativity and pioneering spirit." He added, "Emory University's proficient team will now focus on leveraging this technology to render more cancer types treatable. This audacious initiative can revolutionize our battle against cancer and other challenging medical conditions."

Introduced last year, ARPA-H received an initial allocation of $1 billion. Furthermore, President Biden has proposed an allocation of up to $2.5 billion for the agency in his anticipated 2024 fiscal budget.

TE
━ ABOUT THE BYLINE
TechEchelon Staff

TechEchelon Staff bylines are produced collectively by the newsroom for short, breaking, and wire-style coverage. Longer-form reporting is published under the responsible reporter's name.

More from the Staff
● THE BRIEF · DAILY NEWSLETTER

Five stories every morning. Before the opening bell.

Written for readers who already know the basics — markets, AI, and the policy decisions that shape both.

Mon — Fri · 06:30 ET · Free

No spam · Unsubscribe anytime